BioButton
Continuous vital sign monitoring wearable device for in-facility and at-home patient monitoring
Device · HybridCompany source
Company profile
About BioIntelliSense
BioIntelliSense is a continuous health monitoring and clinical intelligence company that delivers scalable patient monitoring solutions for both in-facility and at-home care settings. The company's flagship BioButton wearable device continuously captures vital signs including heart rate, respiratory rate, skin temperature, and activity levels, transmitting data via Bluetooth to cloud-based analytics platforms. The system is designed to proactively identify early signs of patient deterioration through advanced vitals trending data, enabling clinicians to intervene earlier and improve patient outcomes. BioIntelliSense's monitoring solution integrates with electronic medical records (EMR) and supports various care delivery models including virtual nursing, telemetry overuse reduction programs, and remote patient monitoring (RPM) reimbursement initiatives. The technology has demonstrated clinical impact in reducing unplanned ICU admissions, rapid response team activations, and average length of hospital stay. With a discrete, comfortable design and 14-day battery life, the BioButton device serves health systems, hospitals, and post-acute care providers seeking to enhance patient safety while improving operational efficiency and nurse satisfaction. The company's Data-as-a-Service platform transforms raw vital sign data into actionable clinical insights displayed through the BioDashboard interface, helping care teams prioritize patients who need attention most.
Company description BioIntelliSense official website
Primary marketRemote Patient Monitoring & Wearables
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at BioIntelliSense?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- high-risk patient transfers
- neurological and neurosurgical patients
- patient deterioration
- post-acute care
- post-operative monitoring
- transitional care
Who it serves
- Clinics
- Health Systems
- Hospitals
- Post-Acute Care Providers
Deployment & integration
Cloud Saas · Embedded · Hybrid · On Premise deployment with recorded integration context.
Recorded integration context: EMR/EHR systems.
Geographic context
MarketsUSA
Company sourceOfficial website
Company milestones
Platform expansion
Published observational study in Journal of Clinical Medicine with nearly 12,000 hospitalized patients (2024). Houston Methodist ICU transfer results study published (2025). Participation in Rural Health Transformation (RHT) Program.
Partnerships
Recorded partners
- American Health Network
- Houston Methodist
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
BioDashboard
Exception management software to monitor patients in-hospital and at home
Software · Cloud SaaSCompany source
BioHub Cellular Gateway
Cellular gateway for at-home patient monitoring data transfer
Device · EmbeddedCompany source
BioHub Wi-Fi Gateway
Wi-Fi gateway device for in-facility patient data transfer
Device · On PremiseCompany source
BioMobile App
Patient-facing mobile application for at-home monitoring data transfer
Software · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
A Retrospective Observational Study of Continuous Wireless Vital Sign Monitoring via a Medical Grade Wearable Device on Hospitalized Floor Patients.Journal of clinical medicine · Aug 13, 2024
Clinical validation
Clinical-trial records
BioButton Among Nursing Home ResidentsNCT06665685 · Mentioned · TERMINATED
Remote Monitoring and Home-based Health Care for Treatment of Bone Marrow Transplant PatientsNCT05662631 · Mentioned · COMPLETED
Oncology Care at Home for BMT and CAR-TNCT05826288 · Mentioned · COMPLETED
Remote Temperature Data for Early Detection of Febrile NeutropeniaNCT05180838 · Sponsor · COMPLETED
Prediction of Rehospitalization Following a Sepsis Admission Using a Wearable BiopatchNCT05806762 · Mentioned · RECRUITING
ACCESS A Master Digital Surveillance Protocol for COVID-19NCT04363268 · Sponsor · COMPLETED
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Reduction in unplanned ICU admissions
Studies show comprehensive monitoring compared with standard intermittent vitals
Reduction in rapid response team activations
Multiple studies demonstrating decreased RRT calls
Reduction in average length of hospital stay
Meta-analysis and hospital-specific studies
Earlier detection of patient deterioration
Advanced vitals trending enables proactive intervention
Reduction in 30-day readmission rates
American Health Network analysis of Medicare Advantage patients
Earlier CERT activation
Mortality impact study on ICU transfers
Houston Methodist
Continuous monitoring of high-risk patients undergoing transfer and ICU admissions
Study of 1,120 high-risk patients showed life-saving potential; earlier activation of Clinical Emergency Response Team (CERT) with mortality impact on ICU transfers
American Health Network
Reducing 30-day readmissions for Medicare Advantage patients
Reduced 30-day readmission rates for Medicare Advantage patients discharged from American Health Network
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from BioIntelliSense
Recent articles published on BioIntelliSense's official website.
Solving for Telemetry Overuse in Patient Monitoring with BioIntelliSense
Read on BioIntelliSenseBioIntelliSense Partners with Hicuity Health
Read on BioIntelliSenseBioIntelliSense Announces FDA Clearance of the BioButton® Multi-Patient Wearable and BioDashboard™
Read on BioIntelliSenseEarlier Detection, Better Outcomes: Houston Methodist ICU Transfer Results with BioButton
Read on BioIntelliSenseHouston Methodist and BioIntelliSense Announce Strategic Collaboration
Read on BioIntelliSense07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Remote Patient Monitoring & Wearables
Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.